Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» eczema
eczema
Zai Lab bombs Phase IIa trial in atopic dermatitis, junks the program to shift resources to the pipeline
Endpoints
Sat, 08/25/18 - 09:38 pm
Zai Lab
ZL-3101
Fugan
eczema
Shanghai
clinical trials
2 Biotech Stocks Near All-Time Highs: Can They Keep Climbing?
Motley Fool
Mon, 03/19/18 - 11:41 am
biotech
BeiGene
China
Celgene
AnaptysBio
ANB020
eczema
Sanofi and Regeneron's Dupixent launch is about to get a cash infusion
Fierce Pharma
Wed, 01/10/18 - 10:07 am
Sanofi
Regeneron
Dupixent
drug launches
eczema
JPMHC 2018
Pfizer's Eucrisa beats Dupixent to the DTC punch in eczema, thanks to first-to-market status
Fierce Pharma
Wed, 08/23/17 - 11:21 am
Pfizer
Eucrisa
DTC
eczema
Dupixent
Sanofi
Regeneron
Dermira Commits $135M for Global Rights to Roche Eczema Drug
Xconomy
Tue, 08/8/17 - 11:15 pm
Demira
Roche
eczema
lebrikizumab
Sanofi's eczema rollout Dupixent hits blockbuster launch trajectory as earnings beat
Fierce Pharma
Mon, 07/31/17 - 10:19 pm
Sanofi
eczema
Dupixent
drug launches
earnings
Analyst: Payer hurdles hit dispense rates on Sanofi and Regeneron's eczema blockbuster-to-be Dupixent
Fierce Pharma
Sun, 07/16/17 - 02:53 pm
payers
Sanofi
Regeneron
eczema
Dupixent
dupilumab
Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts
Fierce Pharma
Mon, 05/8/17 - 11:38 am
Sanofi
Regeneron
drug launches
Dupixent
eczema
Sanofi Genzyme hit with patent lawsuit over new eczema drug
Bizjournals.com
Thu, 04/20/17 - 09:48 am
Sanofi Genzyme
patents
eczema
Dupixent
Immunex
Amgen
Regeneron's Game-Changing New Eczema Drug Could Be a Blockbuster
Motley Fool
Thu, 03/30/17 - 09:39 am
Regeneron
eczema
Sanofi
Dupixent
Can a $37,000 price be right? For Dupixent, analysts (and one payer) say yes
Fierce Pharma
Wed, 03/29/17 - 11:58 am
drug pricing
Dupixent
Sanofi
Regeneron
eczema
FDA approves Regeneron, Sanofi $37,000 per year eczema drug
Yahoo/Reuters
Tue, 03/28/17 - 12:28 pm
FDA
Dupixent
Sanofi
Regeneron
eczema
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Yahoo/Reuters
Thu, 03/23/17 - 09:32 am
Sanofi
Roche
GSK
FDA
Ocrevus
MS
Dupixent
eczema
generics
Advair
Mylan Labs
Sanofi, Regeneron Sue Amgen to Avoid Dupixent Patent Claims
Investopedia
Wed, 03/22/17 - 09:58 am
Sanofi
Regeneron
Dupixent
Amgen
patents
eczema
Sanofi, Regeneron say latest Dupixent eczema drug tests positive
Yahoo/Reuters
Sat, 03/4/17 - 01:54 pm
Sanofi
Regeneron
Dupixent
eczema
clinical trials
Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout
Endpoints
Fri, 12/16/16 - 11:34 am
Novartis
eczema
dermatology
M&A
ZPL389
Ziarco
FDA approves Pfizer ointment for chronic itchy skin condition
Yahoo/Reuters
Thu, 12/15/16 - 10:04 am
FDA
Pfizer
eczema
crisaborole
FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme
Bizjournals.com
Mon, 09/26/16 - 09:45 am
FDA
Sanofi Genzyme
Regeneron
Sarilumab
dupilumab
eczema
rheumatoid arthritis
Next-generation eczema drugs on pace for 2017 launch
BioPharma Dive
Wed, 06/1/16 - 09:41 pm
eczema
drug launches
Anacor
Regeneron
Sanofi
Pfizer's Big Bet on Eczema With Anacor Acquisition
Investopedia
Tue, 05/24/16 - 10:04 am
Pfizer
Anacor
M&A
eczema
crisaborole
Pages
« first
‹ previous
1
2
3
4
next ›
last »